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DIAGNOSIS 
EBV is not commonly confirmed as an etiologic agent of acute hepatitis, with 
infection confirmed via serology (heterophile or specific antibodies) or 
immunofluorescence and molecular biologic techniques to confirm the presence in 
biopsy specimen.  The EBV-specific serology can initially be negative in patients 
who have been ill for only a few days.  However, within 1-2 weeks, antibodies to 
EBV-specific antigens appear at the expected titers. 
(A)                                                               (B) 
(A)  Low grade mononuclear lobular inflammation, typical of EBV-related 
hepatitis, like that seen in the general population with hepatitis related to 
infectious mononucleosis. Note the slight increase in sinusoidal lymphocytes 
and "indian-filing" along the sinusoids. 
(B)  In situ hybridization for EBV EBER RNA. In this photomicrograph, note the 
nuclear staining of the lymphocytes scattered within the sinusoids [arrow]. 
TREATMENT 
Treatment for primary Epstein-Barr viral hepatitis is usually supportive as it is 
generally self-limiting.  Steroids and antiviral medications have been utilized to 
treat cases of severe viral hepatitis.  Acyclovir has not been shown to be 
efficacious in the treatment of severe EBV hepatitis.  There are case reports 
on the use of ganciclovir in immunocompetent patients with severe viral 
hepatitis.  However, randomized studies have not been performed for these 
treatments.  In our case, our patient soon recovered with only conservative 
treatment. 
DISCUSSION  
We should consider Epstein-Barr viral hepatitis in differentiating 
patients presenting with liver abnormality, fever, pharyngitis, and 
lymphadenopathy. 
 
HISTORY  
The classic presentation is that of fever, oropharyngitis, and 
lymphadenitis.  Hepatosplenomegaly may also be present.  In a small 
percentage of patients, jaundice and scleral icterus occur. 
 
PHYSICAL EXAM 
Physical exam frequently reveals lymphadenopathy, most common in  
the cervical chain as well as axilla.  Frequently, there is tonsillar 
enlargement with injection.  Splenomegaly is also present.  Rarely, 
patients will present with jaundice as well as scleral icterus due to the 
presence of increased levels of bilirubin. 
 
DIAGNOSTIC TESTS 
Diagnosis primarily relies on the clinical presentation with a high index  
of clinical suspicion, supported by laboratory findings: 
• Atypical lymphocytes 
• Aminotransferases 
• Bilirubin 
• EBV IgM antibodies 
• Heterophile antibody test 
• Negative serology for  
• Hepatitis A, B, C 
• HIV 
• CMV 
• Varicella zoster 
• Herpes simplex virus 
• Serum PCR 
• Pathology 
• Immunofluorescence 
• Molecular techniques, e.g. in situ hybridization 
 
 
 TREATMENT 
• Supportive 
• Steroids 
• Antiviral medications 
• Acyclovir without proven efficacy 
• Case reports of ganciclovir 
• Transplantation if fulminant hepatic failure 
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OBJECTIVE 
To present a case of liver disease with cholestatic features secondary 
to Epstein-Barr virus 
 
INTRODUCTION  
Primary Epstein-Barr virus (EBV) infection in children is typically 
asymptomatic with seroconversion.  If primary infection occurs in 
adolescence or adulthood, the most common manifestation is 
infectious mononucleosis, with symptoms of fever, lymphadenopathy, 
hepatosplenomegaly, and pharyngitis.  Although mild and transient 
elevation of serum aminotransferases is common, jaundice is 
uncommon and complete recovery is the rule.  Cholestatic liver 
disease presenting with an elevation of serum alkaline phosphatase 
and bilirubin is rare, with the mechanism unclear.  EBV has no direct 
cytotoxic effect on hepatic cells, yet destruction is caused by the toxic 
action of free radicals through lipid peroxidation.  Patients with 
Epstein-Barr virus have autoantibodies directed against enzyme 
superoxide-dismutase which neutralizes the enzyme’s antioxidant 
action.  As a result, free radicals accumulate in hepatic cells and 
cause damage.  Rarely, this results in hepatic failure and severe 
jaundice.  
 
CASE PRESENTATION  
An 18-year-old Latino male with no significant past medical history 
presented with diffuse abdominal pain and fever of 8 days duration.  
He had no history of smoking or alcohol abuse, and no family history 
of liver disease.  He noted recent sexual intercourse with a new 
partner.  He had no recent travel, with travel to Mexico one year prior.  
His family had recently acquired a stray dog.   On admission, he 
demonstrated scleral icterus, mild jaundice, left anterior cervical 
lymphadenopathy and inguinal lymphadenopathy, hepatomegaly, and 
right upper quadrant tenderness.  The liver function tests reported 
aspartate aminotransferase 253 IU/L, alanine aminotransferase 373 
IU/L, alkaline phosphatase 181, and total bilirubin 3.7.  Abdominal 
ultrasound demonstrated splenomegaly.  A hepatitis panel with 
serology for hepatitis A, B, and C was negative.  Flow cytometry for 
leukemia and lymphoma was negative.  Serology for Epstein-Barr 
virus and parvovirus were positive.  Serum PCR for EBV was 10,500 
copies/mL and parvovirus PCR was negative.  A liver biopsy 
demonstrated lymphocytic inflammation consistent with EBV hepatitis. 
